The effects of daily consumption of grapefruit on body weight, lipids, and blood pressure in healthy, overweight adults

Caitlin A. Dow, Scott B Going, Hsiao-Hui Chow, Bhimanagouda S. Patil, Cynthia Thomson

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Folklore has suggested that consuming grapefruit may promote weight control. Sparse data exist to support this hypothesis, although there is some evidence of health promotion effects with regard to blood pressure control and modulation of circulating lipids. The aim of this randomized controlled trial was to prospectively evaluate the role of grapefruit in reducing body weight and blood pressure and in promoting improvements in the lipid profile in overweight adults (N = 74). Following a 3-week washout diet low in bioactive-rich fruits and vegetables, participants were randomized to either the control diet (n = 32) or daily grapefruit (n = 42) in the amount of one half of a fresh Rio-Red grapefruit with each meal (3× daily) for 6 weeks. No differences between group in weight, blood pressure, or lipids were demonstrated. Grapefruit consumption was associated with modest weight loss (-0.61 ± 2.23 kg, P =.097), a significant reduction in waist circumference (-2.45 ± 0.60 cm, P =.0002), and a significant reduction in systolic blood pressure (-3.21 ± 10.13 mm Hg, P =.03) compared with baseline values. Improvements were observed in circulating lipids of those consuming grapefruit, with total cholesterol and low-density lipoprotein significantly decreasing by -11.7 mg/dL (P =.002) and -18.7 mg/dL (P <.001), respectively, compared with baseline values. This study suggests that consumption of grapefruit daily for 6 weeks does not significantly decrease body weight, lipids, or blood pressure as compared with the control condition. However, the improvements in blood pressure and lipids demonstrated in the intervention group suggest that grapefruit should be further evaluated in the context of obesity and cardiovascular disease prevention.

Original languageEnglish (US)
Pages (from-to)1026-1035
Number of pages10
JournalMetabolism: Clinical and Experimental
Volume61
Issue number7
DOIs
StatePublished - Jul 2012

Fingerprint

Citrus paradisi
Body Weight
Blood Pressure
Lipids
Folklore
Diet
Weights and Measures
Waist Circumference
Health Promotion
Vegetables
LDL Cholesterol
Meals
Weight Loss
Fruit
Cardiovascular Diseases
Randomized Controlled Trials
Obesity

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

The effects of daily consumption of grapefruit on body weight, lipids, and blood pressure in healthy, overweight adults. / Dow, Caitlin A.; Going, Scott B; Chow, Hsiao-Hui; Patil, Bhimanagouda S.; Thomson, Cynthia.

In: Metabolism: Clinical and Experimental, Vol. 61, No. 7, 07.2012, p. 1026-1035.

Research output: Contribution to journalArticle

@article{bf39464902904ea88da8ed6dce5d6012,
title = "The effects of daily consumption of grapefruit on body weight, lipids, and blood pressure in healthy, overweight adults",
abstract = "Folklore has suggested that consuming grapefruit may promote weight control. Sparse data exist to support this hypothesis, although there is some evidence of health promotion effects with regard to blood pressure control and modulation of circulating lipids. The aim of this randomized controlled trial was to prospectively evaluate the role of grapefruit in reducing body weight and blood pressure and in promoting improvements in the lipid profile in overweight adults (N = 74). Following a 3-week washout diet low in bioactive-rich fruits and vegetables, participants were randomized to either the control diet (n = 32) or daily grapefruit (n = 42) in the amount of one half of a fresh Rio-Red grapefruit with each meal (3× daily) for 6 weeks. No differences between group in weight, blood pressure, or lipids were demonstrated. Grapefruit consumption was associated with modest weight loss (-0.61 ± 2.23 kg, P =.097), a significant reduction in waist circumference (-2.45 ± 0.60 cm, P =.0002), and a significant reduction in systolic blood pressure (-3.21 ± 10.13 mm Hg, P =.03) compared with baseline values. Improvements were observed in circulating lipids of those consuming grapefruit, with total cholesterol and low-density lipoprotein significantly decreasing by -11.7 mg/dL (P =.002) and -18.7 mg/dL (P <.001), respectively, compared with baseline values. This study suggests that consumption of grapefruit daily for 6 weeks does not significantly decrease body weight, lipids, or blood pressure as compared with the control condition. However, the improvements in blood pressure and lipids demonstrated in the intervention group suggest that grapefruit should be further evaluated in the context of obesity and cardiovascular disease prevention.",
author = "Dow, {Caitlin A.} and Going, {Scott B} and Hsiao-Hui Chow and Patil, {Bhimanagouda S.} and Cynthia Thomson",
year = "2012",
month = "7",
doi = "10.1016/j.metabol.2011.12.004",
language = "English (US)",
volume = "61",
pages = "1026--1035",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - The effects of daily consumption of grapefruit on body weight, lipids, and blood pressure in healthy, overweight adults

AU - Dow, Caitlin A.

AU - Going, Scott B

AU - Chow, Hsiao-Hui

AU - Patil, Bhimanagouda S.

AU - Thomson, Cynthia

PY - 2012/7

Y1 - 2012/7

N2 - Folklore has suggested that consuming grapefruit may promote weight control. Sparse data exist to support this hypothesis, although there is some evidence of health promotion effects with regard to blood pressure control and modulation of circulating lipids. The aim of this randomized controlled trial was to prospectively evaluate the role of grapefruit in reducing body weight and blood pressure and in promoting improvements in the lipid profile in overweight adults (N = 74). Following a 3-week washout diet low in bioactive-rich fruits and vegetables, participants were randomized to either the control diet (n = 32) or daily grapefruit (n = 42) in the amount of one half of a fresh Rio-Red grapefruit with each meal (3× daily) for 6 weeks. No differences between group in weight, blood pressure, or lipids were demonstrated. Grapefruit consumption was associated with modest weight loss (-0.61 ± 2.23 kg, P =.097), a significant reduction in waist circumference (-2.45 ± 0.60 cm, P =.0002), and a significant reduction in systolic blood pressure (-3.21 ± 10.13 mm Hg, P =.03) compared with baseline values. Improvements were observed in circulating lipids of those consuming grapefruit, with total cholesterol and low-density lipoprotein significantly decreasing by -11.7 mg/dL (P =.002) and -18.7 mg/dL (P <.001), respectively, compared with baseline values. This study suggests that consumption of grapefruit daily for 6 weeks does not significantly decrease body weight, lipids, or blood pressure as compared with the control condition. However, the improvements in blood pressure and lipids demonstrated in the intervention group suggest that grapefruit should be further evaluated in the context of obesity and cardiovascular disease prevention.

AB - Folklore has suggested that consuming grapefruit may promote weight control. Sparse data exist to support this hypothesis, although there is some evidence of health promotion effects with regard to blood pressure control and modulation of circulating lipids. The aim of this randomized controlled trial was to prospectively evaluate the role of grapefruit in reducing body weight and blood pressure and in promoting improvements in the lipid profile in overweight adults (N = 74). Following a 3-week washout diet low in bioactive-rich fruits and vegetables, participants were randomized to either the control diet (n = 32) or daily grapefruit (n = 42) in the amount of one half of a fresh Rio-Red grapefruit with each meal (3× daily) for 6 weeks. No differences between group in weight, blood pressure, or lipids were demonstrated. Grapefruit consumption was associated with modest weight loss (-0.61 ± 2.23 kg, P =.097), a significant reduction in waist circumference (-2.45 ± 0.60 cm, P =.0002), and a significant reduction in systolic blood pressure (-3.21 ± 10.13 mm Hg, P =.03) compared with baseline values. Improvements were observed in circulating lipids of those consuming grapefruit, with total cholesterol and low-density lipoprotein significantly decreasing by -11.7 mg/dL (P =.002) and -18.7 mg/dL (P <.001), respectively, compared with baseline values. This study suggests that consumption of grapefruit daily for 6 weeks does not significantly decrease body weight, lipids, or blood pressure as compared with the control condition. However, the improvements in blood pressure and lipids demonstrated in the intervention group suggest that grapefruit should be further evaluated in the context of obesity and cardiovascular disease prevention.

UR - http://www.scopus.com/inward/record.url?scp=84862133204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862133204&partnerID=8YFLogxK

U2 - 10.1016/j.metabol.2011.12.004

DO - 10.1016/j.metabol.2011.12.004

M3 - Article

C2 - 22304836

AN - SCOPUS:84862133204

VL - 61

SP - 1026

EP - 1035

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 7

ER -